Barclays Issues Positive Forecast for Keurig Dr Pepper (NASDAQ:KDP) Stock Price

Keurig Dr Pepper (NASDAQ:KDP) had its price target upped by equities research analysts at Barclays from $38.00 to $41.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s price objective would suggest a potential upside of 11.34% from the company’s previous close.

A number of other research firms have also recently commented on KDP. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Keurig Dr Pepper from $30.00 to $32.00 and gave the stock a “hold” rating in a research note on Friday, August 7th. JPMorgan Chase & Co. lifted their price target on shares of Keurig Dr Pepper from $39.00 to $41.00 and gave the stock an “overweight” rating in a research note on Wednesday. Argus restated a “buy” rating and issued a $36.00 price target on shares of Keurig Dr Pepper in a research note on Tuesday, September 15th. HSBC upgraded Keurig Dr Pepper from a “hold” rating to a “buy” rating and boosted their target price for the stock from $37.00 to $40.00 in a research note on Thursday, August 13th. Finally, Bank of America upped their target price on shares of Keurig Dr Pepper from $35.00 to $38.00 in a report on Friday, July 10th. Ten equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $37.29.

Keurig Dr Pepper Stock Up 0.1%

Shares of KDP traded up $0.04 during midday trading on Thursday, reaching $36.83. 11,733,231 shares of the stock were exchanged, compared to its average volume of 12,299,308. The company has a market capitalization of $50.11 billion, a P/E ratio of 33.77, a PEG ratio of 1.65 and a beta of 0.35. The company has a current ratio of 0.52, a quick ratio of 0.28 and a debt-to-equity ratio of 0.73. Keurig Dr Pepper has a 52 week low of $24.88 and a 52 week high of $37.88. The company’s 50 day moving average is $32.68 and its two-hundred day moving average is $30.11.

Keurig Dr Pepper (NASDAQ:KDP) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.62 by $0.04. The business had revenue of $7.34 billion during the quarter, compared to analyst estimates of $7.33 billion. Keurig Dr Pepper had a net margin of 7.12% and a return on equity of 11.27%. The company’s quarterly revenue was up 70.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.54 EPS. On average, sell-side analysts anticipate that Keurig Dr Pepper will post 2.30 earnings per share for the current year.

Insider Transactions at Keurig Dr Pepper

In other news, Director Aaron Alt acquired 7,862 shares of the company’s stock in a transaction that occurred on Tuesday, August 25th. The stock was purchased at an average cost of $31.83 per share, with a total value of $250,247.46. Following the purchase, the director directly owned 7,862 shares of the company’s stock, valued at approximately $250,247.46. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Angela Stephens sold 9,500 shares of Keurig Dr Pepper stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $32.70, for a total transaction of $310,650.00. Following the transaction, the vice president owned 55,786 shares of the company’s stock, valued at approximately $1,824,202.20. The trade was a 14.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.34% of the company’s stock.

Hedge Funds Weigh In On Keurig Dr Pepper

Several large investors have recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new position in Keurig Dr Pepper during the 2nd quarter worth $4,697,645,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in Keurig Dr Pepper in the second quarter valued at approximately $767,105,000. Dimensional Fund Advisors LP grew its stake in shares of Keurig Dr Pepper by 1.1% during the first quarter. Dimensional Fund Advisors LP now owns 9,585,791 shares of the company’s stock worth $252,408,000 after purchasing an additional 103,505 shares during the period. Bank of America Corp DE bought a new stake in Keurig Dr Pepper in the second quarter valued at approximately $281,503,000. Finally, Legal & General Group Plc bought a new position in shares of Keurig Dr Pepper during the 2nd quarter valued at about $269,336,000. 93.99% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Keurig Dr Pepper

Here are the key news stories impacting Keurig Dr Pepper this week:

• Positive Sentiment: Barclays reaffirmed its Buy rating. UBS raised its target to $42 and kept a Buy rating; JPMorgan raised its target to $41 with an Overweight rating, and Morgan Stanley lifted its target to $40, also maintaining Overweight. These calls reinforce optimism about KDP’s prospects. Barclays reaffirms Buy rating
• Positive Sentiment: Energy-drink market share topped 10% following brand acquisitions, and beverage growth helped KDP beat Q3 earnings expectations. The JDE Peet’s acquisition also boosted reported sales growth. Three key takeaways for long-term investors
• Neutral Sentiment: KDP is planning to separate its coffee and beverage businesses in early 2027. The move could help investors value the different businesses independently, but the split’s eventual impact remains uncertain. The company expects 2026 net sales of $25.9 billion to $26.4 billion. 2026 sales outlook and planned separation
• Negative Sentiment: Coffee demand is soft, with shoppers trading down, and KDP warned of slower U.S. coffee profits in Q4. Q3 sales also fell short of forecasts, tempering the earnings beat. TD Cowen raised its target to $35 but kept a Hold rating, signaling caution at the stock’s recent valuation. KDP flags slower fourth-quarter coffee profits

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.

The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.